🇺🇸 FDA
Patent

US 8916197

Bone marrow-directing drug delivery materials and their applications

granted A61KA61K51/1227A61K9/0019

Quick answer

US patent 8916197 (Bone marrow-directing drug delivery materials and their applications) held by The Board of Regents of the University of Texas System expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K51/1227, A61K9/0019, A61K9/1271, A61P